Log in

Start Your Membership Now

The availability of medications for opioid use disorder (MOUD) has increased—but still doesn’t reflect the availability of medications for other health;conditions. About 45% of opioid treatment programs (OTPs) offer all three approved medications for opioid use disorder (MOUD)—methadone, buprenorphine, and;naltrexone - according;to a recent report,;Availability Of Medications For Opioid Use Disorder In Opioid Treatment Programs. The percentage of OTPs offering the full;range of MOUD;increased from 33% in 2017, but uptake of buprenorphine and naltrexone has been uneven.

All the OTPs surveyed offer methadone. The percentage of . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
Log In
If you are already a member, log in to your account to access this resource and more.

Become A Free Member
You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Tagged As: